Characteristic	Value
Female sex, n (%)	43 (53%)
Experience, years (mean range)	22 (1–36)
Setting, n (%)	52 (60.5%)
Urban	52 (60.5%)
Part rural	20 (23.2%)
Rural	9 (10.5%)
Missing data	5 (5.8%)
Teacher in medical school, n (%)	47 (54.6)
Consultation duration, minutes, n (%)
15	20 (23.2)
20	44 (51.2)
25	9 (10.5)
30	8 (9.3)
Missing data	5 (5.8)
Family history of prostate cancer, n (%)	16 (19.7)
Personal history of prostate cancer, n (%)	1 (1.2)
Favourable to prostate cancer screening for asymptomatic patients, n (%)
Yes	18 (20.9)
No	60 (69.8)
I don’t know	1 (1.2)
Missing data	7 (8.1)
Explains prostate cancer screening controversy to patients, n (%)
Systematically	56 (65.1)
Sometimes	24 (27.9)
Never	1 (1.2)
Missing data	5 (5.8)
Orders PSA testing for asymptomatic patients, n (%)
High risk patients only	58 (67.4)
On patients’ demand	1 (1.2)
Physician’s judgement (excluding high risk patients)	15 (17.4)
Systematically	6 (7.0)
Never	1 (1.2)
Missing data	5 (5.8)

PSA = prostate-specific antigen.